| ORIGINAL ARTICLE |
|
| Year : 2022 | Volume
: 1
| Issue : 2 | Page : 45-50 |
|
|
Assessment of hypoglycemic effect of homoeopathic drug Insulinum in the patients suffering from type 2 diabetes mellitus: A prospective nonrandomized single-blind clinical trial
Nivedita Pattanaik1, Chaturbhuja Nayak2, Xinix Xavier3
1 Department of Materia Medica, Rajasthan Vidyapeeth Homoeopathic Medical College and Hospital, Udaipur, India
2 Homoeopathy University, Jaipur, Rajasthan, India
3 National Homoeopathy Research Institute In Mental Health (NHRIMH), Kottayam, Kerala, India
Correspondence Address:
Dr. Xinix Xavier
Cabin No. 116, National Homoeopathy Research Institute in Mental Health (NHRIMH), Kottayam 686532, Kerala
India
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/jahas.jahas_2_23
|
|
|
Introduction: Diabetes mellitus (DM) is described as a metabolic disorder of multiple etiologies characterized by chronic hyperglycemia with disturbance of carbohydrate, fat, and protein metabolism resulting from defect in insulin secretion, insulin action, or both. The increasing prevalence and incidence of DM in developing countries are due to the trend of urbanization and lifestyle changes, including a “Western-style” diet. However, the exact mechanism is not clearly understood to date. DM is classified broadly into type 1 DM (insulin-dependent DM), which is 5%–10% of all cases, and type 2 DM (noninsulin-dependent DM), which accounts for 90%–95% of all cases of DM. Globally, as of 2013, an estimated 382 million people have type 2 DM making up about 90% of the cases. This is equal to 8.3% of the adult population. In 2015, there were 5 million deaths from DM, that is, in every 6 s one person dies from it. It is the eighth leading cause of death. The evidence given by American Universities Group Diabetes Program suggests that conventional treatment can contribute to early death. Alternatively, homoeopathic intervention being safe and cost-effective, it was proposed to explore the role of an organ remedy Insulinum in reducing the blood sugar level and improving the quality of life of such patients suffering from type 2 DM. Materials and Methods: It was a prospective, observational, nonrandomized, noncontrolled, single-blind clinical trial. Results: Of 155 patients, 50 patients (36 males and 14 females) with type 2 DM were enrolled in the study. After a follow-up period of 12 months of treatment, the analysis was done. In the study population, the fasting blood sugar (FBS) baseline mean value was 7.5 mmol/L, which was reduced to 6.7 mmol/L, and the postprandial blood sugar (PPBS) baseline mean value was 11.6 mmol/L, which was reduced to 10.5 mmol/L at the end of treatment. The mean haemoglobin (HbA1C)% value was 8.066% at the baseline, whereas at the end of the treatment, it was reduced to 6.656% and the baseline DM mean score (based on cardinal symptoms of DM) was 8.8, which was reduced to 2.02 at the end of the treatment. Conclusion: The hypoglycemic effect of homoeopathic organ remedy Insulinum during the treatment of type 2 DM was confirmed through this study. The medicine was also helped to improve the quality of life of the patients. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
